FDA Warns of Additional Cancer Risks from Breast Implants
Safety Communication Includes Additional Squamous Cell Carcinoma and Lymphomas On September 8, 2022, the U.S. Food and Drug Administration (FDA) released a Safety Communication, noting reports of additional cancer types [...]